tirofiban has been researched along with Acute Ischemic Stroke in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 38 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H; Liu, J; Yang, Y | 1 |
| Huang, X; Jiang, Z; Liu, H; Ren, Y; Sun, Y; Wang, L; Zheng, H | 1 |
| Jiang, T; Liu, X; Wu, N; Zhang, A | 1 |
| Du, N; Liu, YL; Wang, LX; Yang, L; Yin, XL; Zhao, JS | 1 |
| Huang, S; Liang, Z; Xiang, W; Xu, L; Yang, S; Zhang, J; Zhang, M | 1 |
| Bai, Y; Cao, W; Chang, M; Chen, S; Dai, W; Deng, W; Du, J; Fu, X; Ge, H; Guo, F; Guo, Z; Hong, Y; Hu, J; Hu, W; Hu, Z; Huang, C; Huang, J; Huang, W; Huang, X; Jiang, S; Jin, Y; Jin, Z; Ju, D; Ke, Y; Kong, W; Lei, B; Li, F; Li, H; Li, J; Li, L; Li, R; Liu, S; Liu, T; Liu, W; Long, C; Lu, M; Luo, J; Luo, S; Luo, W; Luo, X; Miao, J; Nogueira, RG; Pan, C; Peng, D; Pu, J; Qi, L; Qiu, Z; Sang, H; Saver, JL; Shi, Z; Song, B; Song, J; Sun, D; Sun, Y; Tian, Y; Tian, Z; Wan, Y; Wang, J; Wang, L; Wang, S; Wang, T; Wang, Y; Wei, L; Wen, C; Wen, H; Wu, D; Wu, J; Wu, Y; Xu, X; Yan, Z; Yang, J; Yang, Q; Yang, S; Yu, Y; Yuan, G; Yuan, J; Yuan, Z; Yue, C; Zeng, G; Zeng, H; Zhang, G; Zhang, J; Zhang, M; Zhang, S; Zhao, W; Zheng, B; Zheng, C; Zhou, P; Zhou, Z; Zhu, X; Zi, W | 1 |
| Chen, J; Duan, J; Guo, W; Ji, X; Li, C; Li, S; Ma, J; Ma, L; Ma, Q; Ren, C; Song, H; Wu, C; Wu, L; Xu, J; Zhao, W | 1 |
| Hu, J; Huang, J; Kong, W; Li, F; Li, L; Liu, S; Luo, W; Nogueira, RG; Qiu, Z; Sang, H; Saver, JL; Song, J; Tian, Y; Yang, J; Yang, Q; Zi, W | 1 |
| Chen, S; Deng, S; Li, T; Lin, B; Liu, Q; Lu, X; Pan, L; Peng, R; Shi, S; Weng, B; Xun, W; Yang, H; Zhang, J | 1 |
| Altmann, S; Brockmann, C; Brockmann, MA; Dillinger, D; Kerz, T; Maus, V; Mpotsaris, A; Othman, AE; Ringel, F; Spreer, A; Waldeck, S | 1 |
| Du, Y; Duan, Z; Li, S; Li, Y; Lian, Y; Liu, R; Ma, C; Wang, H | 1 |
| Chen, Q; Dai, W; Deng, W; Feng, X; Fu, Y; Han, Q; Hu, J; Huang, X; Meng, R; Qiu, Z; Sang, H; Tao, Z; Tian, Y; Wang, T; Wu, D; Xie, D; Yuan, J; Zhang, M; Zuo, L | 1 |
| Fei, Y; Lin, S; Lin, Y; Pan, X; Xu, M; Yang, J; Zou, J | 1 |
| Guo, Y; He, C; Shang, X; Yang, K; Zhou, Z; Zi, W | 1 |
| He, ZF; Hou, MM; Li, XY; Liu, XL; Ren, G; Shi, H; Sun, B | 1 |
| Cheng, J; Hou, Y; Hu, Y; Li, G; Liu, C; Shi, Z; Xiao, Q; Yin, L; Zhu, Q | 1 |
| Ji, X; Jin, F; Ma, H; Ma, Q; Wang, Y; Xu, Y; Zhang, Q | 1 |
| Abdalkader, M; Du, J; Gu, G; Guo, Q; Han, Q; Hu, J; Hu, X; Huang, C; Huang, J; Jiang, B; Jin, Y; Li, F; Liu, S; Liu, T; Luo, S; Mao, A; Nguyen, TN; Pu, J; Qiu, Z; Sang, H; Tao, Z; Wang, L; Yan, Z; Yang, J; Zhao, W; Zhou, S; Zi, W | 1 |
| Chang, M; Hu, Z; Ke, Y; Li, F; Li, L; Li, R; Long, C; Nguyen, TN; Nogueira, RG; Peng, D; Qiu, Z; Ruan, J; Sang, H; Saver, JL; Tian, Y; Tian, Z; Wang, T; Wu, D; Wu, J; Xie, D; Yang, Q; Zhu, X; Zi, W | 1 |
| Aguilar-Pérez, M; Ainz-Gómez, L; Amaya Pascasio, L; Baena-Palomino, P; Bravo Rey, I; Cabezas-Rodríguez, JA; Castellanos Rodrigo, MDM; de Albóniga-Chindurza, A; Delgado-Acosta, F; Díaz Pérez, J; Escudero-Martínez, I; Fernandez Prudencio, L; Freijo Guerrero, MDM; Gamero-García, MÁ; González Díaz, E; González García, A; Hidalgo, C; Jiménez Jorge, S; Jiménez-Gómez, E; Medina-Rodríguez, M; Moniche, F; Montaner, J; Morales Caba, L; Mosteiro, S; Ortega-Quintanilla, J; Oteros Fernández, R; Pardo-Galiana, B; Ramirez Moreno, JM; Rosso Fernández, C; Sanz-Fernandez, G; Vielba-Gomez, I; Zamora, A; Zapata-Arriaza, E | 1 |
| Li, G; Liu, C; Liu, M; Wang, J; Yang, X | 2 |
| Lin, ZH; Zhang, ZM; Zhu, GL | 1 |
| Cai, T; Cao, M; Chen, X; Chen, Z; Cheng, D; Geng, W; Guo, C; He, P; He, W; Hu, J; Huang, F; Huang, J; Huang, W; Huang, X; Kong, W; Li, B; Li, F; Li, H; Li, L; Li, Z; Liang, H; Liu, C; Liu, J; Liu, S; Liu, W; Liu, Z; Luo, J; Miao, J; Mu, J; Nogueira, RG; Peng, Y; Qiu, Z; Saver, JL; Shi, Q; Shi, Z; Song, J; Tan, X; Tang, M; Tang, Y; Tian, Y; Wan, Y; Wang, D; Wang, M; Wang, P; Wu, Y; Xie, S; Xie, W; Yang, D; Yang, J; Yang, Q; Yang, S; Yao, L; Yu, Y; Yu, Z; Yue, C; Zhang, B; Zhao, H; Zheng, J; Zi, W | 1 |
| Wang, P; Yang, Z; Yin, X | 1 |
| Guan, Q; Li, J; Li, X; Lv, W; Ni, H; Xie, Z; Xu, Y; Yun, W; Zhang, L; Zhang, Q; Zhou, J | 1 |
| Alberts, MJ | 1 |
| Gao, Y; Ma, QL; Zhou, J | 1 |
| Liu, B; Qu, H; Sun, Y; Wang, R; Zhang, H; Zhang, S; Zhang, W | 1 |
| Guo, ZN; Qin, H; Sun, Y; Wang, M; Wang, Y; Yan, X; Yang, Y; Zhang, P; Zhu, H | 1 |
| Guo, Y; Li, H; Shen, J; Wang, R; Wang, Y; Yao, Q; Yu, X; Zhang, P | 1 |
| Chen, M; Dai, X; Deng, X; Fu, S; Gong, Q; He, W; Huang, L; Li, C; Luo, Q; Qiu, T; Wang, J; Wang, M; Xiao, H | 1 |
| Chen, Y; Fu, B; Li, P | 1 |
| Tang, L; Tang, X; Yang, Q | 1 |
| Cao, W; Dong, Q; Feng, Y; Ling, Y; Mao, Y; Rong, X; Wang, Z; Zhao, H | 1 |
| Bernava, G; Brina, O; Carrera, E; Corniola, MV; Hofmeister, J; Kulcsar, Z; Lovblad, KO; Machi, P; Meling, TR; Muster, M; Reymond, P; Rosi, A; Yilmaz, H | 1 |
| Chang, W; Li, L; Lin, F; Liu, H; Yin, J; Zhang, H; Zhao, Y | 1 |
| Chen, C; Hu, W; Liu, D; Liu, J; Liu, T; Luo, W; Song, J; Tao, C; Yuan, X; Zhang, C; Zhu, Y | 1 |
12 review(s) available for tirofiban and Acute Ischemic Stroke
| Article | Year |
|---|---|
Efficacy outcomes and safety measures of intravenous tirofiban or eptifibatide for patients with acute ischemic stroke: a systematic review and meta-analysis of prospective studies.
Topics: Brain Ischemia; Eptifibatide; Humans; Ischemic Stroke; Prospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Continuous intravenous tirofiban can improve the 90-day functional outcome and decrease 90-day mortality without increasing bleeding risk in acute ischemic stroke patients treated by endovascular therapy: A meta-analysis.
Topics: Administration, Intravenous; Cohort Studies; Endovascular Procedures; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2022 |
Early tirofiban administration for patients with acute ischemic stroke treated with intravenous thrombolysis or bridging therapy: Systematic review and meta-analysis.
Topics: Administration, Intravenous; Brain Ischemia; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2022 |
Tirofiban for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.
Topics: Brain Ischemia; Endovascular Procedures; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2023 |
Meta-analysis of the efficacy and safety of tirofiban in patients with acute ischaemic stroke undergoing mechanical thrombectomy.
Topics: Brain Ischemia; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Systematic review and meta-analysis of the efficacy and safety of adjunctive use of tirofiban in patients treated with endovascular therapy for acute ischemic stroke at different embolic sites.
Topics: Brain Ischemia; Endovascular Procedures; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Safety and efficacy of tirofiban in acute ischemic stroke patients not receiving endovascular treatment: a systematic review and meta-analysis.
Topics: Administration, Intravenous; Brain Ischemia; Endovascular Procedures; Fibrinolytic Agents; Humans; Ischemic Stroke; Randomized Controlled Trials as Topic; Retrospective Studies; Tirofiban; Treatment Outcome | 2020 |
Safety and efficacy of tirofiban combined with endovascular therapy compared with endovascular therapy alone in acute ischemic stroke: a meta-analysis.
Topics: Brain Ischemia; Endovascular Procedures; Humans; Ischemic Stroke; Prospective Studies; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2021 |
Efficacy and safety of tirofiban therapy in patients receiving endovascular treatment after large vessel ischaemic stroke: A systematic review and meta-analysis.
Topics: Aged; Combined Modality Therapy; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Tirofiban; Treatment Outcome | 2020 |
The Application of Tirofiban in the Endovascular Treatment of Acute Ischemic Stroke: A Meta-Analysis.
Topics: Aged; Cerebral Hemorrhage; Endovascular Procedures; Female; Functional Status; Humans; Ischemic Stroke; Male; Middle Aged; Motor Activity; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recovery of Function; Risk Assessment; Risk Factors; Time Factors; Tirofiban; Treatment Outcome | 2021 |
Sequential tirofiban infusions combined with endovascular treatment may improve outcomes in acute ischemic stroke - a meta-analysis.
Topics: Endovascular Procedures; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Tirofiban; Treatment Outcome | 2021 |
Acute Stenting and Concomitant Tirofiban Administration for the Endovascular Treatment of Acute Ischemic Stroke Related to Intracranial Artery Dissections: A Single Center Experience and Systematic Review of the Literature.
Topics: Administration, Intravenous; Adult; Aged; Aortic Dissection; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Time Factors; Tirofiban; Treatment Outcome; Vascular Patency; Young Adult | 2021 |
10 trial(s) available for tirofiban and Acute Ischemic Stroke
| Article | Year |
|---|---|
Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study.
Topics: Brain Ischemia; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Prospective Studies; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome | 2022 |
Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Arterial Occlusive Diseases; Brain Ischemia; Double-Blind Method; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Platelet Aggregation Inhibitors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2022 |
RESCUE BT 2, a multicenter, randomized, double-blind, double-dummy trial of intravenous tirofiban in acute ischemic stroke: Study rationale and design.
Topics: Aspirin; Double-Blind Method; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2023 |
The efficacy and safety of intravenous tirofiban in the treatment of acute ischemic stroke patients with early neurological deterioration.
Topics: Brain Ischemia; Humans; Ischemic Stroke; Stroke; Tirofiban; Treatment Outcome | 2022 |
Analysis of risk factors for the efficacy of tirofiban in the treatment of acute ischemic stroke.
Topics: Brain Ischemia; Cholesterol; Fibrinolytic Agents; Humans; Ischemic Stroke; Retrospective Studies; Risk Factors; Stroke; Tirofiban; Treatment Outcome | 2023 |
Association between intravenous tirofiban and intracranial hemorrhage in acute large vessel occlusion stroke: insight from the RESCUE BT randomized placebo-controlled trial.
Topics: Aged; Brain Ischemia; Endovascular Procedures; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Association of Tirofiban With Functional Outcomes After Thrombectomy in Acute Ischemic Stroke Due to Intracranial Atherosclerotic Disease.
Topics: Aged; Brain Ischemia; Endovascular Procedures; Female; Humans; Intracranial Arteriosclerosis; Ischemic Stroke; Male; Middle Aged; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Safety and efficacy of tirofiban in acute ischemic stroke due to tandem lesions undergoing mechanical thrombectomy: A multicenter randomized clinical trial (ATILA) protocol.
Topics: Aspirin; Brain Ischemia; Clinical Trials, Phase IV as Topic; Humans; Ischemic Stroke; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Thrombectomy; Thrombosis; Tirofiban; Treatment Outcome | 2023 |
Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion.
Topics: Aspirin; Brain Ischemia; Cerebral Arterial Diseases; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome | 2023 |
Tirofiban combined with heparin's effect and safety in the treatment of mild to moderate acute ischemic stroke.
Topics: Adult; Aged; Aspirin; Clopidogrel; Female; Heparin; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome | 2021 |
16 other study(ies) available for tirofiban and Acute Ischemic Stroke
| Article | Year |
|---|---|
Effect of Tirofiban on new cerebral microbleeds after mechanical thrombectomy in patients with acute ischemic stroke.
Topics: Brain Ischemia; Cerebral Hemorrhage; Fibrinolytic Agents; Humans; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2021 |
Effect of tirofiban in treating patients with progressive ischemic stroke.
Topics: Cerebral Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Safety and efficacy of different tirofiban administration routes on acute ischemic stroke patients with successful recanalization: A propensity score matching analysis.
Topics: Brain Ischemia; Cohort Studies; Humans; Intracranial Hemorrhages; Ischemic Stroke; Propensity Score; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Safety Profile and Complication Rates in Emergency Off-label Use of Tirofiban in Interventional Neuroradiology : An Observational Dual Center Study.
Topics: Adult; Aged; Aged, 80 and over; Fibrinolytic Agents; Humans; Ischemic Stroke; Middle Aged; Off-Label Use; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2023 |
Association of Intravenous Tirofiban with Functional Outcomes in Acute Ischemic Stroke Patients with Acute Basilar Artery Occlusion Receiving Endovascular Thrombectomy.
Topics: Basilar Artery; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Influence of tirofiban on stroke outcome after mechanical thrombectomy in acute vertebrobasilar artery occlusion.
Topics: Arterial Occlusive Diseases; Arteries; Brain Ischemia; Cerebral Hemorrhage; Hospital Mortality; Humans; Ischemic Stroke; Retrospective Studies; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2022 |
Effects of Antecedent Intravenous Thrombolysis on Endovascular Treatment of Acute Stroke Using Tirofiban.
Topics: Brain Ischemia; Cerebral Hemorrhage; Fibrinolytic Agents; Humans; Ischemic Stroke; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2023 |
Factors affecting the outcomes of tirofiban after endovascular treatment in acute ischemic stroke: Experience from a single center.
Topics: Brain Ischemia; Endovascular Procedures; Humans; Ischemic Stroke; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2023 |
Tirofiban in the treatment of cancer-associated ischemic stroke.
Topics: Aspirin; Brain Ischemia; Humans; Ischemic Stroke; Neoplasms; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2023 |
Clinical efficacy and the influence of fibrinogen, homocysteine and prognosis in acute ischemic stroke patients treated with tirofiban plus TERVO stent thrombectomy.
Topics: Brain Ischemia; Fibrinogen; Hemostatics; Homocysteine; Humans; Ischemic Stroke; Retrospective Studies; Stents; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Association of tirofiban with improvement of functional outcomes of direct thrombectomy for acute anterior circulation occlusion: a retrospective, nonrandomized, multicenter, real-world study.
Topics: Brain Ischemia; Cerebral Hemorrhage; Endovascular Procedures; Humans; Ischemic Stroke; Male; Retrospective Studies; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
In ischemic stroke without large or medium vessel occlusion, tirofiban increased likelihood of an excellent outcome.
Topics: Brain Ischemia; Humans; Ischemic Stroke; Stroke; Tirofiban; Treatment Outcome | 2023 |
Early administration of tirofiban after urokinase-mediated intravenous thrombolysis reduces early neurological deterioration in patients with branch atheromatous disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Ischemic Stroke; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Prognosis; Prospective Studies; Thrombolytic Therapy; Time Factors; Time-to-Treatment; Tirofiban; Treatment Outcome; Urokinase-Type Plasminogen Activator; Young Adult | 2020 |
2019 novel coronavirus disease with secondary ischemic stroke: two case reports.
Topics: Aspirin; Atorvastatin; Brain Ischemia; COVID-19; Fibrinolytic Agents; Humans; Ischemic Stroke; Male; Middle Aged; Pandemics; SARS-CoV-2; Tirofiban | 2021 |
Assessing the Efficacy and Safety of Tirofiban in Combination With Dual-antiplatelet Therapy in Progressive Ischemic Stroke Patients.
Topics: Aged; Aspirin; Clopidogrel; Disability Evaluation; Dual Anti-Platelet Therapy; Female; Functional Status; Hemorrhage; Humans; Infusions, Intravenous; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Recovery of Function; Retrospective Studies; Time Factors; Tirofiban; Treatment Outcome | 2021 |
Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke.
Topics: Aspirin; China; Clopidogrel; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Prospective Studies; Tirofiban | 2021 |